Skip to main content
. Author manuscript; available in PMC: 2014 Sep 20.
Published in final edited form as: ACS Chem Biol. 2013 Jul 26;8(9):2063–2071. doi: 10.1021/cb400258d

Figure 1.

Figure 1

Central hypothesis for folate-targeted nanoparticle (NP) delivery in cancer. It is based on a biophysical mechanism in which a folate-conjugated multivalent dendrimer NP adsorbs more strongly to the malignant cell surface expressing folate receptor (FAR) in a higher density (B) than to the normal cell (A).